Paul Kelly
Board Member
Relmada Therapeutics, Inc. (RLMD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paul Kelly
Paul Kelly is recorded as Board Member and COO at Relmada Therapeutics, Inc. (RLMD). Relmada Therapeutics, Inc. reported in an 8-K filed December 15, 2025 that Paul Kelly was appointed Chief Operating Officer, effective January 1, 2025. Relmada Therapeutics, Inc. reported in an 8-K filed January 6, 2025 that Paul Kelly was appointed Chief Operating Officer, effective January 1, 2025.
“On behalf of Relmada Therapeutics, Inc: (the “Company”), I am pleased to offer you the position of Chief Operating Officer.”
“Effective January 1, 2025, Paul Kelly was elected by the Board of Directors (the “Board”) to the position of Chief Operating Officer of Relmada Therapeutics, Inc. (the “Company”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Relmada Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Sergio Traversa CEO, Board Member
- Charles J. Casamento Chairman, Board Member
- Maged Shenouda CFO
- Charles Ence Chief Accounting Officer
- Fabiana Fedeli Board Member
- John Glasspool Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.